Co-Authors
This is a "connection" page, showing publications co-authored by Guizhen Wu and George Gao.
Connection Strength
0.394
-
Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microbes Infect. 2020 Dec; 9(1):1238-1241.
Score: 0.057
-
Excretion of SARS-CoV-2 through faecal specimens. Emerg Microbes Infect. 2020 Dec; 9(1):2501-2508.
Score: 0.057
-
Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020 11 17; 11(1):5859.
Score: 0.057
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
Score: 0.057
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.055
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.055
-
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
Score: 0.055